The Business Plan for funding the third funding gap

Our 35 years of finely honed business planning and operations experience, including the medical cannabis industry, will assist your team in producing a business plan for funding the third funding gap – building the premises.

This is a Business Plan to help finance the building of the Production Facility in anticipation of the Health Canada pre-licensing inspection letter, (the “PLI Letter). This will also include the funding of fixtures such as security vault, lights, cannabis extraction technology, machinery and equipment and working capital to fund the final stages of the Licensing Process.

Business Plans for funding usually for the raising of between four and thirty million dollars, and can be used as the genesis of the Business Plan for an IPO or merger and acquisition (“M&A”) at a late date.

We will ensure that the Business Plan for funding the medical marijuana operations is crafted, and packaged for presentation to investors, to ensure a clear value proposition that investors will want to buy into your future cannabis business.

The Business Plan for funding the third funding gap will comprise:

The Executive Summary (short form business plan for investors) –

  A. Business Plan

1. The Business Opportunity

     2. The Production Capacity & Revenue Streams

3. The Value Proportions

4. The Growing Market

5. Quantification of the Adult Use market

B. Leadership Team

1. Leadership/ Team (Health Canada and Corporate)

2. Detailed Bios

C. Canadian Cannabis Industry Analysis

1. Canadian Regulatory Environment & Trends

2. Identification of Market Segments

3. Canadian Medical Market 

4. Quantification of the Medical Market

5. Quantification of the Adult Use Market under the Cannabis Act

6. A snapshot of the USA Market

7. Export Market Summary

D. Competitive Analysis

1. Full Competitor Analysis including and valuations of some of the significant Licensed Producers public companies, and some private companies.

E. Product Description

1. Medical Processed Products

2. Clones and other similar products

3. Products for the adult use market (Summer 2018)

F. Market and Sales Strategy

1. Marketing Strategy

2. Revenue Models

3. Sales Strategy/Roll out strategy

4. Marketing communications

G. Proposed Operations

1. Growing and other Technologies Capacity

2. Capacity first License

3. Further Capacity Roll Outs in the Future

H. Financial Strategy

1. EBITDA Revenue Summery Tables

2. Use of Funds

3. Financial Assumptions

4. CAPEX